Preparation and Characterization of the Myricetin-loaded PLGA Surfaced Modified with Folic Acid-bound Chitosan and Evaluation of its Antitumor and Antiangiogenic Activities in vitro and in vivo in Mice-bearing Tumor Models

[1]  Mohammad Mashreghi,et al.  Redox-sensitive doxorubicin liposome: a formulation approach for targeted tumor therapy , 2022, Scientific Reports.

[2]  Tariq Ahmad Masoodi,et al.  Targeting cancer signaling pathways by natural products: Exploring promising anti-cancer agents. , 2022, Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie.

[3]  Qi Li,et al.  Myricetin Suppresses Ovarian Cancer In Vitro by Activating the p38/Sapla Signaling Pathway and Suppressing Intracellular Oxidative Stress , 2022, Frontiers in Oncology.

[4]  J. Chamani,et al.  B12-functionalized PEGylated liposomes for the oral delivery of insulin: In vitro and in vivo studies , 2022, Journal of Drug Delivery Science and Technology.

[5]  S. Ramakrishna,et al.  Nanofibrous drug delivery systems for breast cancer: a review , 2021, Nanotechnology.

[6]  Krishna Das Saha,et al.  Chitosan-Decorated PLGA-NPs Loaded with Tannic Acid/Vitamin E Mitigate Colon Cancer via the NF-κB/β-Cat/EMT Pathway , 2021, ACS omega.

[7]  Nusaiba K. Al-Nemrawi,et al.  Preparation and characterization of Docetaxel-PLGA nanoparticles coated with folic acid-chitosan conjugate for cancer treatment. , 2021, Journal of pharmaceutical sciences.

[8]  A. Es‐haghi,et al.  Biosynthesis and characterisation of solid lipid nanoparticles and investigation of toxicity against breast cancer cell line , 2021, IET nanobiotechnology.

[9]  M. Shakibaei,et al.  Flavonoids as an effective sensitizer for anti-cancer therapy: insights into multi-faceted mechanisms and applicability towards individualized patient profiles , 2021, EPMA Journal.

[10]  Yujie Huang,et al.  Myricetin inhibits TNF-α-induced inflammation in A549 cells via the SIRT1/NF-κB pathway. , 2021, Pulmonary pharmacology & therapeutics.

[11]  Jin-jian Lu,et al.  Natural Products in Cancer Therapy: Past, Present and Future , 2021, Natural Products and Bioprospecting.

[12]  Zemene Demelash Kifle,et al.  A recent development of new therapeutic agents and novel drug targets for cancer treatment , 2021, SAGE Open Medicine.

[13]  J. Pei,et al.  Myricetin: A review of the most recent research. , 2020, Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie.

[14]  J. Loureiro,et al.  PLGA Based Drug Carrier and Pharmaceutical Applications: The Most Recent Advances , 2020, Pharmaceutics.

[15]  B. Salehi,et al.  Myricetin bioactive effects: moving from preclinical evidence to potential clinical applications , 2020, BMC Complementary Medicine and Therapies.

[16]  J. Chamani,et al.  Folate targeted PEGylated liposomes for the oral delivery of insulin: In vitro and in vivo studies. , 2020, Colloids and surfaces. B, Biointerfaces.

[17]  Mohammad Mashreghi,et al.  Preparation and characterization of stable nanoliposomal formulations of Curcumin with high loading efficacy: In vitro and in vivo anti-tumor study. , 2020, International journal of pharmaceutics.

[18]  J. Qian,et al.  Method for enhancing bioavailability of myricetin based on self-assembly of casein-myricetin nanomicelles. , 2020, IET nanobiotechnology.

[19]  Mohammad Mashreghi,et al.  Development of chitosan-coated liposome for pulmonary delivery of N-acetylcysteine. , 2019, International journal of biological macromolecules.

[20]  Mohammad Mashreghi,et al.  Endogenous Stimuli-Responsive Linkers in Nanoliposomal Systems for Cancer Drug Targeting. , 2019, International journal of pharmaceutics.

[21]  A. Bishayee,et al.  Natural product-based nanoformulations for cancer therapy: Opportunities and challenges. , 2019, Seminars in cancer biology.

[22]  B. Amini,et al.  Folic acid functionalized nanoparticles as pharmaceutical carriers in drug delivery systems , 2019, Drug development research.

[23]  F. Kiessling,et al.  PLGA-Based Nanoparticles in Cancer Treatment , 2018, Front. Pharmacol..

[24]  F. Pessine,et al.  Formulation of functionalized PLGA nanoparticles with folic acid-conjugated chitosan for carboplatin encapsulation , 2018, European Polymer Journal.

[25]  Leonardo Fernandes Fraceto,et al.  Nano based drug delivery systems: recent developments and future prospects , 2018, Journal of Nanobiotechnology.

[26]  Yinghao Sun,et al.  The Natural Compound Myricetin Effectively Represses the Malignant Progression of Prostate Cancer by Inhibiting PIM1 and Disrupting the PIM1/CXCR4 Interaction , 2018, Cellular Physiology and Biochemistry.

[27]  Wing Man Lau,et al.  Chitosan and Its Derivatives for Application in Mucoadhesive Drug Delivery Systems , 2018, Polymers.

[28]  Yingying Zhang,et al.  Plasma membrane changes during programmed cell deaths , 2017, Cell Research.

[29]  E. Wasan,et al.  An Overview of Chitosan Nanoparticles and Its Application in Non-Parenteral Drug Delivery , 2017, Pharmaceutics.

[30]  Behzad Baradaran,et al.  The Different Mechanisms of Cancer Drug Resistance: A Brief Review , 2017, Advanced pharmaceutical bulletin.

[31]  Paul S. Sheeran,et al.  Intracellular delivery and ultrasonic activation of folate receptor-targeted phase-change contrast agents in breast cancer cells in vitro. , 2016, Journal of controlled release : official journal of the Controlled Release Society.

[32]  A. Viljoen,et al.  Myricetin: A Dietary Molecule with Diverse Biological Activities , 2016, Nutrients.

[33]  V. Gupta,et al.  Cytotoxic effects of oosporein isolated from endophytic fungus Cochliobolus kusanoi , 2015, Front. Microbiol..

[34]  J. Davoodi,et al.  Up regulation of Bax and down regulation of Bcl2 during 3-NC mediated apoptosis in human cancer cells , 2015, Cancer Cell International.

[35]  P. Doležel,et al.  Influence of different formulations and process parameters during the preparation of drug-loaded PLGA microspheres evaluated by multivariate data analysis , 2014, Acta pharmaceutica.

[36]  Hsing-Wen Sung,et al.  Recent advances in chitosan-based nanoparticles for oral delivery of macromolecules. , 2013, Advanced drug delivery reviews.

[37]  G. Mansoori,et al.  Utilizing the folate receptor for active targeting of cancer nanotherapeutics , 2012, Nano reviews.

[38]  P. Low,et al.  Folate receptor alpha as a tumor target in epithelial ovarian cancer. , 2008, Gynecologic oncology.